Study S001652

Intravenous Exenatide Infusion in Critically Ill Patients With Acute Brain Injury

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT02058940
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 8
Start: 2015-08
Primary completion: 2017-08
Lead sponsor: University of North Carolina, Chapel Hill
Conditions: Brain Injuries
Interventions: DRUG:Exenatide
Results posted: TRUE
Secondary identifiers: OTHER_GRANT:Astra Zeneca Pharmaceuticals; OTHER_GRANT:Medtronic MiniMed, Inc

Registered primary outcomes

Percentage of Critically Ill Patients With Acute Brain Injury Achieving Pre-specified Feasibility Criteria [Over 48 hours from infusion initiation]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.